A股異動 | 桂林三金(002275.SZ)大漲逾6% 藥品獲納入肺炎治療
格隆匯2月26日丨桂林三金(002275.SZ)今日大幅高開拉漲,一度衝高至8%。現升6.17%,報15.14元,暫成交7859.77萬元,最新總市值89.36億元。桂林三金昨晚公告,公司玉葉解毒顆粒被列入廣西新冠病毒肺炎中醫藥治療方案(試行第三版)。玉葉解毒顆粒被該治療方案列為中醫藥治療醫學觀察期和臨牀治療期(確診病例)輕型或普通型濕熱藴肺證的推薦用藥。玉葉解毒顆粒是公司全資子公司湖南三金的獨家專利品種。市場人士認為,公司獨家藥被列入治療範圍,一度程度上給公司帶來利好,且品牌價值得到認證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.